Abstract
There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Current Pharmaceutical Design
Title: Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Volume: 16 Issue: 24
Author(s): Cristian R. Munteanu, Enrique Fernandez-Blanco, Jose A. Seoane, Pilar Izquierdo-Novo, Jose Angel Rodriguez-Fernandez, Jose Maria Prieto-Gonzalez, Juan R. Rabunal and Alejandro Pazos
Affiliation:
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Abstract: There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Export Options
About this article
Cite this article as:
R. Munteanu Cristian, Fernandez-Blanco Enrique, A. Seoane Jose, Izquierdo-Novo Pilar, Angel Rodriguez-Fernandez Jose, Maria Prieto-Gonzalez Jose, R. Rabunal Juan and Pazos Alejandro, Drug Discovery and Design for Complex Diseases through QSAR Computational Methods, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389252
DOI https://dx.doi.org/10.2174/138161210792389252 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Use of Unsaturated Fatty Acids in Liposomal Form to Get Bread Enriched with ω-3 Fatty Acids
Current Nutrition & Food Science Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities
Current Pharmaceutical Design Cardioprotective Peptides from Marine Sources
Current Protein & Peptide Science Pharmacogenetic Modulation of Platelet Inhibition
Current Pharmacogenomics and Personalized Medicine Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity
Current Drug Targets Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Females Live Longer than Males: Role of Oxidative Stress
Current Pharmaceutical Design The Association between Metabolic Syndrome and Serum Levels of Adiponectin and High Sensitive C Reactive Protein in Gorgan
Endocrine, Metabolic & Immune Disorders - Drug Targets Cholesterol Efflux and Reverse Cholesterol Transport: Experimental Approaches
Current Medicinal Chemistry Characterization of Supraventricular Tachycardia in Infants: Clinical and Instrumental Diagnosis
Current Pharmaceutical Design Functional and Structural Benefits Induced by Omega-3 Polyunsaturated Fatty Acids During Aging
Current Neuropharmacology Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Current Pharmaceutical Design Behcets Syndrome: Literature Review
Current Rheumatology Reviews Statins as Antihypertensives
Recent Patents on Cardiovascular Drug Discovery Gender Differences in Response to Therapy for Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine Cardiometabolic Risk Related to the Association of hypertriglyceridemia-Low HDLc
Current Pharmaceutical Design Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Current HIV Research Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India
Cardiovascular & Hematological Agents in Medicinal Chemistry